EC Number   |
Title |
Organism |
|---|
    4.1.1.9 | Chemical-genetic induction of malonyl-CoA decarboxylase in skeletal muscle |
Mus musculus |
| 4.1.1.9 | Design, synthesis and in vitro evaluation of some small molecules malonyl CoA decarboxylase inhibitors containing pyrazoline scaffold and study of their binding interactions with malonyl CoA decarboxylase via preliminary docking simulation |
Homo sapiens |
| 4.1.1.9 | Effect of inhibiting malonyl-CoA decarboxylase on cardiac remodeling after myocardial infarction in rats |
Rattus norvegicus |
| 4.1.1.9 | Genetic and pharmacological inhibition of malonyl CoA decarboxylase does not exacerbate age-related insulin resistance in mice |
Mus musculus |
| 4.1.1.9 | Identification of the active site of human mitochondrial malonyl-coenzyme A decarboxylase A combined computational study |
Homo sapiens |
| 4.1.1.9 | Phosphorylation of Ser-204 and Tyr-405 in human malonyl-CoA decarboxylase expressed in silkworm Bombyx mori regulates catalytic decarboxylase activity |
Homo sapiens |
| 4.1.1.9 | 3D-QSAR studies on malonyl coenzyme A decarboxylase inhibitors |
Rattus norvegicus |
| 4.1.1.9 | A highly sensitive high-throughput luminescence assay for malonyl-CoA decarboxylase |
Homo sapiens |
| 4.1.1.9 | A role for peroxisome proliferator-activated receptor alpha (PPARalpha) in the control of cardiac malonyl-CoA levels. Reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase |
Mus musculus |
| 4.1.1.9 | Activation of malonyl-CoA decarboxylase in rat skeletal muscle by contraction and the AMP-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside |
Rattus norvegicus |
